Lilly Officially Pleads Guilty In Zyprexa Debacle
Weeks after Eli Lilly & Co. announced a record-breaking $1.4 billion deal to settle charges that it illegally marketed its anti-psychotic treatment Zyprexa for off-label use, the pharmaceutical giant formally pled...To view the full article, register now.
Already a subscriber? Click here to view full article